Immunic, Inc.

IMUX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$26-$27-$25-$25
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$2$0
Change in WC$2$0$2$0
Other Non-Cash$4$0$0$2
Operating Cash Flow-$20-$25-$22-$23
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$65$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$65$65$0$0
Financing Cash Flow$0$66$0$0
Forex Effect$0$0$0-$1
Net Chg. in Cash-$20$41-$21-$23
Supplemental Information
Beg. Cash$55$14$36$59
End Cash$35$55$14$36
Free Cash Flow-$20-$25-$22-$23
Immunic, Inc. (IMUX) Financial Statements & Key Stats | AlphaPilot